دورية أكاديمية
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
| العنوان: | Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial) |
|---|---|
| المؤلفون: | Casile, MélanieAff1, Aff3, IDs12885024124152_cor1, Albrand, Gilles, Lahaye, Clément, Lebecque, BenjaminAff1, Aff3, Besombes, JoévinAff1, Aff3, Bourgne, CélineAff1, Aff3, Pereira, Bruno, Saugues, SandrineAff1, Aff5, Jamot, CarolineAff1, Aff5, Hermet, Eric, Berger, Marc G.Aff1, Aff3, Aff5 |
| المصدر: | BMC Cancer. 24(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-12415-2 |